PURPOSE: Myelomastocytic leukemia is a term used for patients with advanced myeloid neoplasms, in whom elevated numbers of immature atypical mast cells are found, but criteria for a primary mast cell disease are not met. The origin of mast cells in these patients is presently unknown. PATIENT AND METHODS: We have analyzed clonality of mast cells in an 18-year-old patient suffering from acute myeloid leukemia with a complex karyotype including a t(8;21) and mastocytic transformation with a huge increase in immature mast cells and elevated serum tryptase level, but no evidence for a primary mast cell disease/mastocytosis. RESULTS: As assessed by in situ fluorescence hybridization combined with tryptase staining, both the tryptase-negative blast cells and the tryptase-positive mast cells were found to contain the t(8;21)-specific AML1/ETO fusion gene. Myeloablative stem cell transplantation resulted in complete remission with consecutive disappearance of AML1/ETO transcripts, decrease of serum tryptase to normal range, and disappearance of neoplastic mast cells. CONCLUSION: These data suggest that mast cells directly derive from the leukemic clone in patients with myelomastocytic leukemia.
PURPOSE:Myelomastocytic leukemia is a term used for patients with advanced myeloid neoplasms, in whom elevated numbers of immature atypical mast cells are found, but criteria for a primary mast cell disease are not met. The origin of mast cells in these patients is presently unknown. PATIENT AND METHODS: We have analyzed clonality of mast cells in an 18-year-old patient suffering from acute myeloid leukemia with a complex karyotype including a t(8;21) and mastocytic transformation with a huge increase in immature mast cells and elevated serum tryptase level, but no evidence for a primary mast cell disease/mastocytosis. RESULTS: As assessed by in situ fluorescence hybridization combined with tryptase staining, both the tryptase-negative blast cells and the tryptase-positive mast cells were found to contain the t(8;21)-specific AML1/ETO fusion gene. Myeloablative stem cell transplantation resulted in complete remission with consecutive disappearance of AML1/ETO transcripts, decrease of serum tryptase to normal range, and disappearance of neoplastic mast cells. CONCLUSION: These data suggest that mast cells directly derive from the leukemic clone in patients with myelomastocytic leukemia.
Authors: Celalettin Ustun; Andreas Reiter; Bart L Scott; Ryotaro Nakamura; Gandhi Damaj; Sebastian Kreil; Ryan Shanley; William J Hogan; Miguel-Angel Perales; Tsiporah Shore; Herrad Baurmann; Robert Stuart; Bernd Gruhn; Michael Doubek; Jack W Hsu; Eleni Tholouli; Tanja Gromke; Lucy A Godley; Livio Pagano; Andrew Gilman; Eva Maria Wagner; Tor Shwayder; Martin Bornhäuser; Esperanza B Papadopoulos; Alexandra Böhm; Gregory Vercellotti; Maria Teresa Van Lint; Christoph Schmid; Werner Rabitsch; Vinod Pullarkat; Faezeh Legrand; Ibrahim Yakoub-Agha; Wael Saber; John Barrett; Olivier Hermine; Hans Hagglund; Wolfgang R Sperr; Uday Popat; Edwin P Alyea; Steven Devine; H Joachim Deeg; Daniel Weisdorf; Cem Akin; Peter Valent Journal: J Clin Oncol Date: 2014-08-25 Impact factor: 44.544
Authors: Carlos E Vigil; Sa A Wang; Jorge E Cortes; Carlos Bueso-Ramos; Srdan Verstovsek; Roman Shinder; Su S Chen; Ruth L Katz; Abha Khanna; Bita Esmaeli; John T Manning; M James You; Roberto N Miranda Journal: J Clin Oncol Date: 2011-04-04 Impact factor: 44.544
Authors: P Valent; K Sotlar; W R Sperr; L Escribano; S Yavuz; A Reiter; T I George; H C Kluin-Nelemans; O Hermine; J H Butterfield; H Hägglund; C Ustun; J L Hornick; M Triggiani; D Radia; C Akin; K Hartmann; J Gotlib; L B Schwartz; S Verstovsek; A Orfao; D D Metcalfe; M Arock; H-P Horny Journal: Ann Oncol Date: 2014-03-27 Impact factor: 32.976
Authors: Sheeja T Pullarkat; Vinod Pullarkat; Steven H Kroft; Carla S Wilson; Arshad N Ahsanuddin; Karen P Mann; Maung Thein; Wayne W Grody; Russell K Brynes Journal: J Hematop Date: 2009-02-10 Impact factor: 0.196
Authors: Peter Valent; Attilio Orazi; Guntram Büsche; Annette Schmitt-Gräff; Tracy I George; Karl Sotlar; Berthold Streubel; Christine Beham-Schmid; Sabine Cerny-Reiterer; Otto Krieger; Arjan van de Loosdrecht; Wolfgang Kern; Kiyoyuki Ogata; Friedrich Wimazal; Judit Várkonyi; Wolfgang R Sperr; Martin Werner; Hans Kreipe; Hans-Peter Horny Journal: Oncotarget Date: 2010-11
Authors: Won Kyu Choi; Young Uk Cho; Eunkyoung You; Seongsoo Jang; Eul Ju Seo; Chan Jeoung Park Journal: Ann Lab Med Date: 2017-05 Impact factor: 3.464